2851 - 2860 of 8808 Results
Title
Year
- Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action2020OPENTitle: Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionJournal Name: European NeuropsychopharmacologyPublisher: Elsevier BVVol: 36Issue #:Start Page: 121End Page: 136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.euroneuro.2020.05.006Best OA location URL: https://hdl.handle.net/11250/2729974Citation Count: 20
-
OPENTitle: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialistsJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 22Issue #: 3Start Page: 574End Page: 580Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/s41436-019-0684-xBest OA location URL: https://www.nature.com/articles/s41436-019-0684-x.pdfCitation Count: 59
-
OPENTitle: Prevalence of REM sleep behavior disorder in Sun City, ArizonaJournal Name: HeliyonPublisher: Elsevier BVVol: 6Issue #: 1Start Page: e03140End Page: e03140Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e03140Best OA location URL: http://www.cell.com/article/S2405844019367994/pdfCitation Count: 14
-
OPENTitle: A revolution in biochemistry and molecular biology education informed by basic research to meet the demands of 21st century career pathsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 295Issue #: 31Start Page: 10653End Page: 10661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.aw120.011104Best OA location URL: https://doi.org/10.1074/jbc.aw120.011104Citation Count: 16
-
OPENTitle: New transgenic models of Parkinson's disease using genome editing technologyJournal Name: Neurología (English Edition)Publisher: Elsevier BVVol: 35Issue #: 7Start Page: 486End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006Best OA location URL: https://doi.org/10.1016/j.nrleng.2017.08.006Citation Count: 3
-
RESTRICTEDTitle: Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 739Issue #:Start Page: 135443End Page: 135443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2020.135443Citation Count: 9
-
RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 39
-
OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://www.prd-journal.com/article/S1353802020300973/pdfCitation Count: 46
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 37
-
RESTRICTEDTitle: Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.026Citation Count: 34